NAPSA Drives Innovation and Investment at KOPALA 100 in Kitwe

NAPSA Drives Innovation and Investment at KOPALA 100 in Kitwe

The National Pension Scheme Authority (NAPSA) this week participated in the KOPALA 100 in Kitwe, an annual innovation and investment event organised by the Zambia National Technical Board (ZNTB) under the Ministry of Science and Technology.

The KOPALA 100 continues to serve as a vital platform for connecting innovative start-ups with potential investors, creating opportunities for collaboration and advancing Zambia’s entrepreneurial ecosystem. This year’s event attracted a diverse range of participants, including emerging businesses, established investors, policymakers and industry leaders, all united by a shared commitment to driving innovation-led growth.

NAPSA’s participation underscores its strategic focus on supporting sustainable economic development through targeted investments, particularly within the digital and innovation sectors. As a key institutional investor, the Authority is playing an increasingly important role in enabling the growth of high-potential enterprises that contribute to job creation and economic diversification.

Speaking during the event, the Minister of Science and Technology, Honourable Felix Mutati, commended NAPSA for its continued investment in the digital space and its proactive approach to fostering innovation. He noted that such investments are critical to positioning Zambia as a competitive player in the global knowledge economy.

The Minister further acknowledged NAPSA’s deliberate efforts to support entrepreneurs and investors through innovative financing mechanisms, highlighting the importance of partnerships between the public and private sectors in unlocking economic opportunities.

Through its participation in platforms such as the KOPALA 100, NAPSA continues to demonstrate its commitment to building a resilient and inclusive economy. Central to these efforts is the Zambia Kuchalo Wealth Fund, through which the Authority is supporting entrepreneurs and investors by providing patient capital to high-growth sectors while promoting the development of home-grown enterprises.